Nothing Special   »   [go: up one dir, main page]

GB202214756D0 - Product - Google Patents

Product

Info

Publication number
GB202214756D0
GB202214756D0 GBGB2214756.5A GB202214756A GB202214756D0 GB 202214756 D0 GB202214756 D0 GB 202214756D0 GB 202214756 A GB202214756 A GB 202214756A GB 202214756 D0 GB202214756 D0 GB 202214756D0
Authority
GB
United Kingdom
Prior art keywords
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2214756.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2214756.5A priority Critical patent/GB202214756D0/en
Publication of GB202214756D0 publication Critical patent/GB202214756D0/en
Priority to PCT/GB2023/052591 priority patent/WO2024074837A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2214756.5A 2022-10-07 2022-10-07 Product Ceased GB202214756D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2214756.5A GB202214756D0 (en) 2022-10-07 2022-10-07 Product
PCT/GB2023/052591 WO2024074837A1 (en) 2022-10-07 2023-10-06 Product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2214756.5A GB202214756D0 (en) 2022-10-07 2022-10-07 Product

Publications (1)

Publication Number Publication Date
GB202214756D0 true GB202214756D0 (en) 2022-11-23

Family

ID=84818155

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2214756.5A Ceased GB202214756D0 (en) 2022-10-07 2022-10-07 Product

Country Status (2)

Country Link
GB (1) GB202214756D0 (en)
WO (1) WO2024074837A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113120D0 (en) 1991-06-18 1991-08-07 Kodak Ltd Photographic processing apparatus
GB0411186D0 (en) 2004-05-19 2004-06-23 Celltech R&D Ltd Biological products
WO2009040562A1 (en) 2007-09-26 2009-04-02 Ucb Pharma S.A. Dual specificity antibody fusions
PL2334705T3 (en) 2008-09-26 2017-06-30 Ucb Biopharma Sprl Biological products
WO2013052058A1 (en) * 2011-10-07 2013-04-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
CA2891552A1 (en) * 2012-11-16 2014-05-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Gonorrheal mtre peptides and vaccines
CN105358573B (en) * 2013-05-31 2020-10-30 基因泰克公司 Anti-muramic acid antibodies and conjugates
WO2021234471A1 (en) * 2020-05-17 2021-11-25 Abgenics Lifesciences Private Limited An antibody fragment based antimicrobial conjugate selectively targeting pseudomonas
WO2021234527A1 (en) * 2020-05-17 2021-11-25 Abgenics Lifesciences Private Limited An antibody fragment based antifungal conjugate selectively targeting candida

Also Published As

Publication number Publication date
WO2024074837A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
CA196825S (en) Food product
GB202103213D0 (en) Product dispensers
GB202202060D0 (en) Product
GB201908108D0 (en) Product
GB201903318D0 (en) Product
GB202312812D0 (en) Product distribution
GB202105467D0 (en) Food product
GB202304491D0 (en) Product
GB202304454D0 (en) Product
GB202302255D0 (en) Product
GB202218144D0 (en) Product
GB202216674D0 (en) Product
GB202215233D0 (en) Product
GB202214756D0 (en) Product
GB202211637D0 (en) Product
GB202209424D0 (en) Product
GB202206176D0 (en) Product
GB202104148D0 (en) Product
GB202101453D0 (en) Product
GB202016463D0 (en) Product
GB202215631D0 (en) Construction product
GB202215635D0 (en) Construction product
GB202001470D0 (en) Product
GB202108609D0 (en) Product brief
CA204176S (en) Confectionery product

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)